Kyle A Campbell1, Justin A Colacino2, Sung Kyun Park3,2, Kelly M Bakulski3. 1. Department of Epidemiology, University of Michigan School of Public Health, University of Michigan, Ann Arbor, MI, USA. bakulski@umich.edu. 2. Department of Environmental Health Sciences, University of Michigan School of Public Health, University of Michigan, Ann Arbor, MI, USA. 3. Department of Epidemiology, University of Michigan School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Abstract
PURPOSE OF REVIEW: This article introduces the roles of perinatal DNA methylation in human health and disease, highlights the challenges of tissue and cellular heterogeneity to studying DNA methylation, summarizes approaches to overcome these challenges, and offers recommendations in conducting research in environmental epigenetics. RECENT FINDINGS: Epigenetic modifications are essential for human development and are labile to environmental influences, especially during gestation. Epigenetic dysregulation is also a hallmark of multiple diseases. Environmental epigenetic studies routinely measure DNA methylation in readily available tissues. However, tissues and cell types exhibit specific epigenetic patterning and heterogeneity between samples complicates epigenetic studies. Failure to account for cell-type heterogeneity limits identification of biological mechanisms and biases study results. Tissue-level epigenetic measures represent a convolution of epigenetic signals from individual cell types. Tissue-specific epigenetics is an evolving field and the use of disease-affected target, surrogate, or multiple tissues has inherent trade-offs and affects inference. Likewise, experimental and bioinformatic approaches to accommodate cell-type heterogeneity have varying assumptions and inherent trade-offs that affect inference. The relationships between exposure, disease, tissue-level DNA methylation, cell type-specific DNA methylation, and cell-type heterogeneity must be carefully considered in study design and analysis. Causal diagrams can inform study design and analytic strategies. Properly addressing cell-type heterogeneity limits sources of potential bias, avoids misinterpretation of study results, and allows investigators to distinguish shifts in cell-type proportions from direct changes to cellular epigenetic programming, both of which provide insights into environmental disease etiology and aid development of novel methods for prevention and treatment.
PURPOSE OF REVIEW: This article introduces the roles of perinatal DNA methylation in human health and disease, highlights the challenges of tissue and cellular heterogeneity to studying DNA methylation, summarizes approaches to overcome these challenges, and offers recommendations in conducting research in environmental epigenetics. RECENT FINDINGS: Epigenetic modifications are essential for human development and are labile to environmental influences, especially during gestation. Epigenetic dysregulation is also a hallmark of multiple diseases. Environmental epigenetic studies routinely measure DNA methylation in readily available tissues. However, tissues and cell types exhibit specific epigenetic patterning and heterogeneity between samples complicates epigenetic studies. Failure to account for cell-type heterogeneity limits identification of biological mechanisms and biases study results. Tissue-level epigenetic measures represent a convolution of epigenetic signals from individual cell types. Tissue-specific epigenetics is an evolving field and the use of disease-affected target, surrogate, or multiple tissues has inherent trade-offs and affects inference. Likewise, experimental and bioinformatic approaches to accommodate cell-type heterogeneity have varying assumptions and inherent trade-offs that affect inference. The relationships between exposure, disease, tissue-level DNA methylation, cell type-specific DNA methylation, and cell-type heterogeneity must be carefully considered in study design and analysis. Causal diagrams can inform study design and analytic strategies. Properly addressing cell-type heterogeneity limits sources of potential bias, avoids misinterpretation of study results, and allows investigators to distinguish shifts in cell-type proportions from direct changes to cellular epigenetic programming, both of which provide insights into environmental disease etiology and aid development of novel methods for prevention and treatment.
Entities:
Keywords:
Cellular heterogeneity; DNA methylation; Environment; Epidemiology; Epigenetics; Tissue
Authors: Lucile Broséus; Daniel Vaiman; Jörg Tost; Camino Ruano San Martin; Milan Jacobi; Joel D Schwartz; Rémi Béranger; Rémy Slama; Barbara Heude; Johanna Lepeule Journal: BMC Med Date: 2022-10-20 Impact factor: 11.150
Authors: Lauren Y M Middleton; John Dou; Jonah Fisher; Jonathan A Heiss; Vy K Nguyen; Allan C Just; Jessica Faul; Erin B Ware; Colter Mitchell; Justin A Colacino; Kelly M Bakulski Journal: Epigenetics Date: 2021-02-22 Impact factor: 4.528
Authors: Kelly M Bakulski; Jonah D Fisher; John F Dou; Arianna Gard; Lisa Schneper; Daniel A Notterman; Erin B Ware; Colter Mitchell Journal: Toxics Date: 2021-10-13
Authors: Daniele Fallin; Rebecca J Schmidt; Kelly M Bakulski; John F Dou; Lauren Y M Middleton; Yihui Zhu; Kelly S Benke; Jason I Feinberg; Lisa A Croen; Irva Hertz-Picciotto; Craig J Newschaffer; Janine M LaSalle Journal: Epigenetics Chromatin Date: 2022-08-02 Impact factor: 5.465
Authors: Elana R Elkin; Kelly M Bakulski; Justin A Colacino; Dave Bridges; Brian A Kilburn; D Randall Armant; Rita Loch-Caruso Journal: Arch Toxicol Date: 2021-03-16 Impact factor: 5.153
Authors: Elisabeth B Binder; Darina Czamara; Linda Dieckmann; Cristiana Cruceanu; Marius Lahti-Pulkkinen; Jari Lahti; Tuomas Kvist; Hannele Laivuori; Sara Sammallahti; Pia M Villa; Sanna Suomalainen-König; Rebecca C Rancourt; Andreas Plagemann; Wolfgang Henrich; Johan G Eriksson; Eero Kajantie; Sonja Entringer; Thorsten Braun; Katri Räikkönen Journal: Cell Mol Life Sci Date: 2022-02-03 Impact factor: 9.261